4C4J
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04-1 |
Synchrotron site | Diamond |
Beamline | I04-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2012-02-10 |
Detector | DECTRIS PILATUS |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 69.830, 108.370, 112.700 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 40.650 - 2.500 |
R-factor | 0.1938 |
Rwork | 0.193 |
R-free | 0.20990 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4bi1 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.150 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.4) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.650 | 2.600 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.050 | 0.980 |
Number of reflections | 14969 | |
<I/σ(I)> | 11.8 | 1.2 |
Completeness [%] | 98.9 | 99.5 |
Redundancy | 4.7 | 4.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 14% PEG8000 0.05M MAGNESIUM ACETATE, 0.1M SODIUM ACETATE |